CN106109837A - A kind of Chinese medicine treating coronary heart disease - Google Patents
A kind of Chinese medicine treating coronary heart disease Download PDFInfo
- Publication number
- CN106109837A CN106109837A CN201610735605.4A CN201610735605A CN106109837A CN 106109837 A CN106109837 A CN 106109837A CN 201610735605 A CN201610735605 A CN 201610735605A CN 106109837 A CN106109837 A CN 106109837A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- heart disease
- coronary heart
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine treating coronary heart disease, medicine including following parts by weight is prepared from: the Rhizoma Dioscoreae Hypoglaucae of 25 35 parts by weight, the slack parasitism of 20 30 parts by weight, the Retinervus Luffae Fructus of 25 35 parts by weight, the Hirudo of 5 15 parts by weight, the Semen Strychni of 37 parts by weight, the Semen Citri Reticulatae of 30 40 parts by weight, the Radix Glycyrrhizae of 5 15 parts by weight.The present invention forms with pure traditional Chinese medicine, and scientific formulation is reasonable, and configuration is simple, has no side effect, and curative effect is short, instant effect, is different from the Therapeutic Principle in the past treating coronary heart disease, has effect of expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, removing obstruction for relieving pain, dredge the meridian passage, heat-clearing and toxic substances removing.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine treating coronary heart disease.
Background technology
Coronary atherosclerotic heart disease is coronary artery generation atherosclerotic lesion and causes blood vessel
Chamber stenosis or occlusion, causes myocardial ischemia, anoxia or heart disease that is downright bad and that cause, is commonly referred to as " coronary heart disease ".But hat
The scope of cardiopathia may be more extensive, also includes that inflammation, thromboembolism etc. cause luminal stenosis or obturation.World Health Organization (WHO) is by coronary heart disease
It is divided into 5 big classes: silent ischemia (latent coronary heart disease), angina pectoris, myocardial infarction, ischemic heart failure (ischemic
Heart disease) and 5 kinds of Clinical types of sudden death.Clinic is usually divided into stable coronary heart disease and acute coronary syndrome.
1987～many provinces and cities of China 35 in 1993～64 years old census of population (China MONICA) find, high incidence is
108.7/10 ten thousand (Qingdaos), minimum 3.3/10 ten thousand (Anhui Chuzhou), there is more significant regional difference, north provinces and cities are universal
Higher than south provinces and cities.The prevalence city of coronary heart disease is 1.59%, and rural area is 0.48%, adds up to 0.77%, in rising trend.
Coronary heart disease comes first of the cause of death in the U.S. and many developed countries.But, the U.S., from the sixties in 20th century, goes out
Existing coronary heart disease death rate downward trend.Have benefited from the effort reducing coronary risk factor that the 60-80 age U.S. is carried out, main
If controlling risk factor and improving the treatment of myocardial infarction.Chinese Urban Residents coronary heart disease death in 2009 is rough and careless is 94.96/
100000, rural area is 71.27/10 ten thousand, and city is higher than rural area, and male is higher than women.The method for the treatment of coronary heart disease is controlled with medicine at present
Treating and coronary artery bypass grafting is main, coronary artery bypass grafting is the most costly, and has certain risk, and can not be from solving problem at all；West
Medicine treatment is cured the symptoms, not the disease equally, can only delay the pathological development of coronary heart disease, reduces mortality rate, it is impossible to fundamentally solve patient
Problem；And it is the best, in its prescription in dynamic then tens taste twenties tastes to treat therapeutic effect in the Chinese medicine of coronary heart disease at present
Medicine, has seemed good curative effect, the financial burden of the patient that on the one hand medicine of this big prescription increases the weight of, it is often more important that big group
The use of side's medicine has increased the weight of the toxic and side effects between prescription Chinese medicine, does not only have what due curative effect, also can give and suffer from
Person brings unnecessary potential safety hazard.
Summary of the invention
For the deficiencies in the prior art, the present invention provides a kind of low cost, instant effect, and cure rate is high, has no side effect
The Chinese medicine for the treatment of coronary heart disease.
The technical scheme is that and be achieved in that: a kind of Chinese medicine treating coronary heart disease, including in following parts by weight
Medicine raw material is prepared from: the Rhizoma Dioscoreae Hypoglaucae of 25-35 parts by weight, the slack parasitism of 20-30 parts by weight, the silk of 25-35 parts by weight
Melon network, the Hirudo of 5-15 parts by weight, the Semen Strychni of 3-7 parts by weight, the Semen Citri Reticulatae of 30-40 parts by weight, 5-15 parts by weight
Radix Glycyrrhizae.
Technical scheme can be achieved in that
A kind of Chinese medicine treating coronary heart disease, the medicine including following parts by weight is prepared from: the Rhizoma Dioscoreae Hypoglaucae of 30 parts by weight
, the slack parasitism of 25 parts by weight, the Retinervus Luffae Fructus of 30 parts by weight, the Hirudo of 10 parts by weight, the Semen Strychni of 5 parts by weight,
The Semen Citri Reticulatae of 35 parts by weight, the Radix Glycyrrhizae of 10 parts by weight.
Each raw material is mixed by the present invention, is ground into fine powder, directly takes, and three times a day, each 2-3 gram, warm water takes.
The course for the treatment of: 10 days be a course for the treatment of, the 3-6 course for the treatment of need to be taken.
The pharmacology of each concrete ingredient is as follows:
Rhizoma Dioscoreae Hypoglaucae: bitter is flat；Dampness removing goes turbid, wind expelling stagnation removing.
Slack parasitism: bitter is flat；Wind-damp dispelling, invigorating the liver and kidney, bone and muscle strengthening, antiabortive.
Retinervus Luffae Fructus: sweet is flat；Dredging collateral, invigorates blood circulation, and dispels the wind.
Hirudo: salty, bitter, flat, slightly poisonous；Removing blood stasis, removing blood stasis, stimulates the menstrual flow.
Semen Strychni: bitter, warm, very toxic；Removing obstruction in the collateral to relieve pain, mass dissipating and swelling eliminating.
Semen Citri Reticulatae: bitter is flat；Regulate the flow of vital energy, eliminating stagnation, pain relieving.
Radix Glycyrrhizae: sweet, flat；Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.
The function of the present invention and curing mainly: Rhizoma Dioscoreae Hypoglaucae, slack parasitic expelling wind and removing dampness in the present invention；Retinervus Luffae Fructus, Hirudo blood circulation promoting and blood stasis dispelling；
Semen Strychni, Semen Citri Reticulatae removing obstruction for relieving pain；Retinervus Luffae Fructus, Hirudo dredge the meridian passage；Radix Glycyrrhizae heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription, profit of dispeling the wind played altogether by all medicines
Wet, effect of blood circulation promoting and blood stasis dispelling, removing obstruction for relieving pain, dredge the meridian passage, heat-clearing and toxic substances removing.
Beneficial effects of the present invention: the present invention forms with pure traditional Chinese medicine, scientific formulation is reasonable, and configuration is simple, nontoxic pair
Effect, curative effect is short, instant effect, is different from the Therapeutic Principle in the past treating coronary heart disease, has expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, eliminating stagnation
Pain relieving, dredge the meridian passage, effect of heat-clearing and toxic substances removing.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further details:
Embodiment 1: a kind of Chinese medicine treating coronary heart disease, the medicine including following weight grams is prepared from: the powder of 25 grams
Bi, the slack parasitism of 20 grams, the Retinervus Luffae Fructus of 25 grams, the Hirudo of 5 grams, the Semen Strychni of 3 grams, the Semen Citri Reticulatae of 30 grams, the Radix Glycyrrhizae of 5 grams.
Embodiment 2: a kind of Chinese medicine treating coronary heart disease, the medicine including following weight grams is prepared from: the powder of 35 grams
Bi, the slack parasitism of 30 grams, the Retinervus Luffae Fructus of 35 grams, the Hirudo of 15 grams, the Semen Strychni of 7 grams, the Semen Citri Reticulatae of 40 grams, the Radix Glycyrrhizae of 15 grams.
Embodiment 3: a kind of Chinese medicine treating coronary heart disease, the medicine including following weight grams is prepared from: the powder of 30 grams
Bi, the slack parasitism of 25 grams, the Retinervus Luffae Fructus of 30 grams, the Hirudo of 10 grams, the Semen Strychni of 5 grams, the Semen Citri Reticulatae of 35 grams, the Radix Glycyrrhizae of 10 grams.
Embodiment 4: a kind of Chinese medicine treating coronary heart disease, the medicine including following weight grams is prepared from: the powder of 33 grams
Bi, the slack parasitism of 27 grams, the Retinervus Luffae Fructus of 29 grams, the Hirudo of 7 grams, the Semen Strychni of 4 grams, the Semen Citri Reticulatae of 38 grams, the Radix Glycyrrhizae of 12 grams.
Each raw material is mixed by Chinese medicine in embodiment 1-4 in the preparation, is ground into fine powder, directly takes, three times a day, often
Secondary 2-3 gram, take with warm water.
The present invention is not limited to above-mentioned preferred forms, anyone draw under the enlightenment of the present invention other any with
Product as the present invention is same or like, within all falling within protection scope of the present invention.
The result of clinical observation of the present invention is as follows:
Effective cure rate statistics of the Chinese medicine of the present invention, criterion of therapeutical effect is as follows:
Curing: transference cure, sign recovers normal；
Effective: symptom alleviates, attack times reduces, and the intermission extends, and sign has improvement；
Invalid: symptom, sign are without changing.
The present invention treats patient's totally 153 example participating in statistics, wherein: 132 examples of fully recovering, effective 17 examples, invalid 4 examples, always has
Efficiency reaches 97%.
Model case:
Zhang, man, 53 years old, squeezing property dull pain, there is burn feeling, by here Drug therapy, fully recover after one month.
Pungent certain, female, 49 years old, uncomfortable in chest, breathe hard, dyspnea during outbreak, have no resolution after the treatment of many places, control by here medicine
Treat, fully recover after 40 days.
Huang, man, 37 years old, omoplate district pain, first, second heart sound was overcast, heart failure, treats by here, two
Fully recover after Yue.
Claims (2)
1. the Chinese medicine treating coronary heart disease, it is characterised in that: include that the medicine of following parts by weight is prepared from: 25-35 weight
The slack parasitism of the Rhizoma Dioscoreae Hypoglaucae .20-30 parts by weight of amount number, the Retinervus Luffae Fructus of 25-35 parts by weight, the water of 5-15 parts by weight
Trematodiasis, the Semen Strychni of 3-7 parts by weight, the Semen Citri Reticulatae of 30-40 parts by weight, the Radix Glycyrrhizae of 5-15 parts by weight.
A kind of Chinese medicine treating coronary heart disease the most according to claim 1, it is characterised in that: include the medicine of following parts by weight
Thing is prepared from: the Rhizoma Dioscoreae Hypoglaucae of 30 parts by weight, the slack parasitism of 25 parts by weight, the Retinervus Luffae Fructus of 30 parts by weight, 10 weight portions
The Hirudo of number, the Semen Strychni of 5 parts by weight, the Semen Citri Reticulatae of 35 parts by weight, the Radix Glycyrrhizae of 10 parts by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610735605.4A CN106109837A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610735605.4A CN106109837A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating coronary heart disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106109837A true CN106109837A (en) | 2016-11-16 |
Family
ID=57275398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610735605.4A Pending CN106109837A (en) | 2016-08-26 | 2016-08-26 | A kind of Chinese medicine treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106109837A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947780A (en) * | 2006-08-02 | 2007-04-18 | 李洋 | Traditional Chinese medicine for treating coronary heart disease and angina pectoris |
| CN101879272A (en) * | 2010-06-28 | 2010-11-10 | 南京中医药大学 | Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof |
-
2016
- 2016-08-26 CN CN201610735605.4A patent/CN106109837A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1947780A (en) * | 2006-08-02 | 2007-04-18 | 李洋 | Traditional Chinese medicine for treating coronary heart disease and angina pectoris |
| CN101879272A (en) * | 2010-06-28 | 2010-11-10 | 南京中医药大学 | Chinese medicinal compound for treating coronary heart diseases, preparation method and application thereof |
Non-Patent Citations (1)
| Title |
|---|
| 郑国庆: "风药治血与冠心病心绞痛证治", 《中医药学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101062377B (en) | Adhesive plaster for diminishing inflammation, expelling wind and cold | |
| CN103463500B (en) | Medicament for treating cerebral hemorrhage | |
| CN103536858B (en) | Medicine for treating rheumatoid arthritis | |
| CN101181568B (en) | Traditional chinese medicine preparation for curing osteoproliferation as well as arthrosis ache | |
| CN105687409A (en) | Stone needle mud moxibustion and method for preparing same | |
| CN105169212A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103341047B (en) | Medicament for treating pharyngitis and preparation method thereof | |
| CN102397515A (en) | Plaster for treating rheumatism | |
| CN105233188A (en) | Traditional Chinese medicine composition for treating liver cancer and application of traditional Chinese medicine composition | |
| CN107412491A (en) | A kind of externally applied ointment for treating hyperosteogeny patch and preparation method thereof | |
| CN106109837A (en) | A kind of Chinese medicine treating coronary heart disease | |
| CN106310047A (en) | Traditional Chinese medicine compound for treating skin diseases caused by damp, hot and dry blood and unsmooth vein | |
| CN104740465A (en) | Traditional Chinese medicine composition for treating allergic rhinitis | |
| CN104825598A (en) | External-use plaster for treating rheumatic bone pain and preparation method thereof | |
| CN103893610A (en) | Traditional Chinese medicine ointment for treating tinea of feet and hands and preparation method thereof | |
| CN103751324B (en) | A kind of Traditional Chinese Medicine for external application for the treatment of acute gouty arthritis | |
| CN103705676B (en) | A kind of Chinese medicine preparation preventing and treating thromboangiitis obliterans | |
| CN102283925A (en) | Traditional Chinese medicine for treating neurodynia resulted from herpes zoster | |
| CN102872293A (en) | Traditional Chinese medicinal powder for treating rheumatism and rheumatoid disease | |
| CN102416078A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
| CN106039236A (en) | Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation | |
| CN106039257A (en) | Traditional Chinese medicine mud-moxibustion ointment and preparation method thereof | |
| CN105362786A (en) | Traditional Chinese medicine capsules for treating gall-stone and preparation method thereof | |
| CN104189866A (en) | Externally-used traditional Chinese medicine wine for treating knee joint bone hyperplasia | |
| CN104840823A (en) | Traditional Chinese medicine preparation for treating otitis media and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |